Researchers have uncovered an early survival response in ovarian cancer cells that may limit the effectiveness of widely used PARP inhibitors. A new study from Mayo Clinic researchers reports that ovarian cancer cells can quickly switch on a survival response after treatment with PARP inhibitors. Blocking this early reaction may help these drugs work more […]
Read more about this post…
Credits: Source
Disclaimer
Researchers Discover Surprising New Ovarian Cancer Treatment Using an Existing Drug – Science News
Local Weather
Web Hits
Visitor Count
In-Service

Latest Posts
Related articles




Serving